The pandemic agreement and amended International Health Regulations seek to make the world better prepared for the next pandemic. It is important that the world builds on the lessons learned during COVID-19 so that we can respond more equitably and faster in the future.

In a joint statement released by trade associations representing the global biopharmaceutical industry and developing countries vaccine manufacturers, the industry has outlined its commitments – both in pre-pandemic times and after a pandemic is declared – to deliver equitable access to essential medical countermeasures.

On 18 March, the first day of the 9th Meeting of the Intergovernmental Negotiating Body, we hosted a side event to share the biopharmaceutical industry’s commitments with key stakeholders, building on the Berlin Declaration.

The event gathered senior representatives from governments, multilateral organizations, and the private sector, and was followed by a networking reception.